Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $746.4600 (-0.68%) ($746.4600 - $746.4600) on Wed. Dec. 14, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.66% (three month average) | RSI | 57 | Latest Price | $746.4600(-0.68%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.5% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) DIA(33%) IWD(29%) SPLV(29%) IVW(28%) | Factors Impacting REGN price | REGN will decline at least -0.83% in a week (0% probabilities). TBT(-15%) URA(-4%) VCSH(-3%) ARKG(-3%) ARKK(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.83% (StdDev 1.66%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $748.11 | 5 Day Moving Average | $751.71(-0.7%) | 10 Day Moving Average | $754.88(-1.12%) | 20 Day Moving Average | $748.11(-0.22%) | To recent high | -2.6% | To recent low | 9% | Market Cap | $79.146b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |